Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Dusunen Adam. 2018; 31(4): -


Neutrophil-to-Lymphocyte Ratio as a Potential Differential Diagnostic Marker for Alzheimer’s Disease, Major Depressive Disorder, and Parkinson’s Disease

Hayriye Baykan, Özgür Baykan, Emre Cem Esen, Ayfer Tirak, Serap Akdeniz Görgülü, Tunay Karlıdere.




Abstract

Introduction: Major depressive disorder, Alzheimer’s, and Parkinson’s disease are among the leading causes of dementia in the elderly. These diseases are often misdiagnosed because of overlapping symptoms. This study aimed to evaluate whether neutrophil-to-lymphocyte ratio, which has been used as an indicator of systemic inflammation, can be used for the differential diagnoses of these diseases.

Materials and Method: A total of 95 patients with major depressive disorder, Alzheimer’s, or Parkinson’s disease were enrolled. Blood specimens were drawn from participants and neutrophil-to-lymphocyte ratios were calculated. We compared the three groups according to mean neutrophil-to-lymphocyte ratio and mean neutrophil-to-lymphocyte ratio adjusted for age. We used the Receiver Operating Characteristics curve analysis to predict the sensitivity and specificity of this ratio for the differential diagnosis between depression and Alzheimer’s disease.

Results: The mean neutrophil-to-lymphocyte ratio for the depression, Alzheimer’s, and Parkinson’s disease groups was 2.2 ± 0.7, 2.9 ± 1.2, and 2.2 ± 0.9, respectively (P = 0.005). The adjusted mean neutrophil-to-lymphocyte ratio for age for the depression, Alzheimer’s, and Parkinson’s disease groups was 2.2 ± 0.17, 2.8 ± 0.15, and 2.2 ± 0.2, respectively (P = 0.025). Receiver Operating Characteristics curve analyses predicted that the sensitivity and specificity for the differential diagnosis between depression and Alzheimer’s disease was 54.8% and 80%, respectively.

Conclusion: This study suggested that a simple arithmetic calculation could help clinicians in the differential diagnosis between depression, Alzheimer’s, and Parkinson’s disease. Neutrophil-to-lymphocyte ratio can be used as a secondary line of evidence, along with the initial clinical assessment.

Key words: Inflammation, Alzheimer, Depression, Parkinson's






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.